期刊文献+

体外诱导负载TGF-β1基因的兔关节滑膜细胞向软骨细胞分化 被引量:1

Construction of eucaryotic expression plasmid carrying the recombinant rabbit TGF β1 gene and serf-induction of rabbit articular synoviocytes into chondrocytes in vitro
原文传递
导出
摘要 目的探讨体外诱导负载TGF-β1基因的兔关节滑膜细胞向透明软骨细胞分化的可行性,为组织工程学修复关节软骨损伤提供体外实验依据。方法体外培养扩增B型滑膜细胞并纯化,构建pcDNA3.1-TGF-β1,用Lipofectamine 2000法转染,转染pcDNA3.1-TGF-β1组为实验组,转染pcDNA3.1(+)空质粒组为对照组,未转染组为空白组。转染后48h行G418筛选,RT—PCR检测TGF-β1的瞬时表达,同时取阳性细胞爬片,行抗TGF-β1免疫组织化学染色;G418维持筛选,每2d取部分细胞计数,连续12d,绘制生长曲线,转染后3周,每周取部分细胞爬片行抗TGF-β1和抗Ⅱ型胶原免疫组织化学染色。图像分析采用Image—Pro Plus V6.0软件分析处理,实验数据采用SPSS 13.0行统计学处理,组间两两比较采用方差分析。结果实验组转染后转染率为18%,转染后生长曲线显示细胞早期生长活性下降,细胞数量在转染后第4天降低到3.6×10^4/ml,第3天RT—PCR检测到TGF-β1阳性片段,抗TGF-β1免疫组织化学染色见细胞内阳性颗粒,对照组及空白组均为阴性;细胞转染后第3周,实验组抗TGF-β1及抗Ⅱ型胶原免疫组织化学染色仍见细胞内阳性颗粒,对照组及空白组为阴性;图像分析结果表明,转染后第7天实验组抗TGF-β1的PU值为(19.04±1.26),对照组及空白组PU值分别为(4.07±0.65)和(3.23±0.56),差异有统计学意义(P〈0.05);转染后14d实验组抗Ⅱ型胶原的PU值为(13.74±1.27),对照组及空白组PU值分别为(4.62±0.56)和(3.93±0.38),差异有统计学意义(P〈0.05)。结论脂质体法重组pcDNA3.1-TGF-β1基因可成功转染兔关节滑膜细胞,转染后细胞成功表达TGF-β1,并分泌Ⅱ型胶原蛋白,表现出透明软骨细胞样生理特征,滑膜细胞有望成为一种良好的软骨组织工程的种子细胞。 Objective To investigate the experimental methods of transfecting the synoviocytes with the reconstructed pcDNA3.1-TGF-β1 gene by the liposomes and study the feasibility of self-induction of synoviocytes to the chondrocytes in vitro so as to provide a scientific and experimental basis for the further gene enhanced tissue engineering research in articular cartilage repair. Methods Synoviocytes were cultivate in vitro and purified to construct the eucaryotic expression plasmid carrying the recombinant rabbit TGF-β1 gene. By means of Lipofectamine 2000, the synoviocytes were transfected with pcDNA3.1-TGF-β1 (experimental group) and with pcDNA3. 1 ( + ) blank plasmid (control group). The synoviocytes free from transfection was set as blank group. After 48 hours of transfection, the cells were screened by G418. Representative sections from among the positive clones were used for RT-PCR assay of instant expression of TGF-β1. The other sections were used for immunohistochemical analysis with antibodies to TGF β1. Screening of cells by G418 was continued for 12 days of cell counting and drawing the growth curve. The antigens of TGF-β1 and collagen Ⅱ were examined every week three weeks after transfection. All images were processed by using analysis instrument (Image-Pro Plus V6.0). Statistical analysis was conducted with SPSS 13.0 software package. The difference between groups was tested by using variance (ANOVA) analysis. Results The transfection efficiency in experimental group was 18%, with temporary decreased living activity of the transfected cells shown by growth curve. The cell population decreased to 3.6×10^4/ml four days after transfection. After 72 hours of transfection, the positive fragment of TGF-β1 was detected by RT-PCR assay, and immunohistochemical staining of antibiotics to TGF-β1 showed positive particles only in the experimental group. After three weeks of tranfection, the immunohistochemical analysis with antibodies to TGF-β1 and type Ⅱ collagen showed that there were positive particles in the transfected cells in the experimental group, with no positive particle in the control and blank groups. According to the results of Image-Pro Plus V6.0, PU value of anti-TGF-β1 was ( 19.04± 1.26) seven days after transfection, while that of control and blank groups were (4.07 ± 0.65 ) and (3.23 ± 0.56) respectively, with statistical difference ( P 〈 0.05 ). PU value of anti-type Ⅱ collagen in experimental group, control group and blank group was ( 13.74±1.27), (4.62 ± 0.56) and (3.93±0.38) 14 days after transfection, with statistical difference (P〈0.05). Conclusions Transfection of the rabbit articular synoviocytes with the reconstructed pcDNA3.1 -TGF-β1 gene can be successfully accomplished by using Lipofectamine 2000 method. The transfected synoviocytes can express TGF- β1 and excrete type Ⅱ collagen, have chondrogenic potential when transfected by pcDNA3. 1-TGF-β1 gene and can be used as candidate cells for repair of articular cartilage.
出处 《中华创伤杂志》 CAS CSCD 北大核心 2009年第4期361-366,共6页 Chinese Journal of Trauma
基金 广东省科技计划资助项目(C2005B34001001)
关键词 滑膜 转化生长因子Β 转基因 软骨细胞 组织工程 Synovial membrane Transforming growth factor beta Transgenes Chondrocytes Tissue engineering
  • 相关文献

参考文献14

  • 1陆宁,卢世璧,王继芳,王岩.采用自体成熟关节软骨细胞的软骨组织工程修复[J].中华实验外科杂志,2005,22(3):293-296. 被引量:15
  • 2Kramer J, Bohmsen F, Schlenke P, et al. Stem cell - derived chondrocytes for regenerative medicine. Transplant Proc, 2006, 38 ( 3 ) :742 - 765.
  • 3张正治,刘正津.滑膜细胞的来源及遗传表型[J].解剖科学进展,1998,4(2):126-132. 被引量:8
  • 4Crone MH, Watt I. Synovial chondromatosis. J Bone Joint Surg (Br), 1988, 70(5) :807 -811.
  • 5Allard SA, Maini RN, Muirden KD. Cells and matrix expressing cartilage components in fibroblastic tissue in rheumatoid pannus. Scand J Rheumatol, 1988, 76 : 125 - 129.
  • 6Xue C, Takahashi M, Hasunuma T, et al. Characterization of fibroblast - like cells in pannus lesions of patients with rheumatoid arthritis sharing properties of fibroblasts and chondracytes. Ann Rheum Dis, 1997, 56(4) :262 -267.
  • 7De Bari C, Dell' Accio F, Tylzanowski P, et al. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum, 2001,44(8 ) : 1928 - 1942.
  • 8Sakaguchi Y, Sekiya I, Muneta T, et al. Comparison of human stem cells derived from various mesenchymal tissues:superiority of synovium as a cell source. Arthritis Rheum, 2005, 52(8) :2521 - 2529.
  • 9Arend WP, Dayer J - M. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum, 1990, 33 (3) : 305 -315.
  • 10Hunziker EB, Rosenberg LC. Repair of partial - thickness defects in articular cartilage: cell recruitment from the synovial membrane. J Bone Joint Surg (Am) , 1996, 78(5) :721 -733.

二级参考文献75

  • 1申洪.免疫组织化学染色定量方法研究(Ⅲ)[J].中国组织化学与细胞化学杂志,1995,4(1):89-92. 被引量:398
  • 2王劲,罗成基,徐辉,冉新泽,闫国和,粟永萍,程天民.骨髓间充质干细胞在肌组织局部成肌分化的实验研究[J].中国修复重建外科杂志,2005,19(1):70-73. 被引量:11
  • 3韩冰,付小兵,孙晓庆.骨髓基质细胞基因表达的研究进展[J].中国修复重建外科杂志,2005,19(2):153-158. 被引量:11
  • 4冯林,张锡庆.人脂肪组织来源的干细胞在骨组织工程中的应用[J].中国矫形外科杂志,2005,13(8):620-621. 被引量:1
  • 5Grande DA, Breitbart AS, Mason J, et al. Cartilage tissue engineering: current limitation and solution. Clin Orthop Relat Res, 1999,367 (Suppl) : 176-185.
  • 6Shapiro F, Koide S, Glimcher MJ, et al. Cell origin and differentiation in the repair of full thickness defect of articular cartilage. J Bone Joint Surg(Am), 1993,75(4) :532-553.
  • 7Galera P,Redini F,Vivien D,et al. Effects of transforming growth factor-beta 1 (TGF-beta 1)on matrix synthesis by monolayer cultures of rabbit articular chondrocytes during the dedifferentiation process. Exp Cell Res, 1992,200 (2) :379-392.
  • 8Johnstone B,Yoo JU. Autologous mesenchymal progenitor cells in articular cartilage repair. Clin Orthop Relat Res, 1999, 367(Suppl) : 156-162.
  • 9Evans CH, Ghivizzani SC, Smith P, et al. Using gene therapy to protect and restore cartilage. Clin Orthop Relat Res, 2000, 379(Suppl) :214-219.
  • 10Masson JM, Breitbart AS, Barcia M. et al. Cartilage and bone regeneration using gene-enhanced tissue engineering. Clin Orth Relat Res,2000,379(Suppl) : 171-178.

共引文献39

同被引文献22

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部